Indoco Remedies Limited (NSE:INDOCO)
219.90
+3.21 (1.48%)
Jul 31, 2026, 3:30 PM IST
Indoco Remedies Market Cap
Indoco Remedies has a market cap or net worth of 20.26 billion as of July 31, 2026. Its market cap has decreased by -32.32% in one year.
Market Cap
20.26B
Enterprise Value
30.76B
Revenue
18.73B
Ranking
n/a
PE Ratio
359.85
Stock Price
219.90
ChartMarket Cap Chart
Since January 14, 2005, Indoco Remedies's market cap has increased from 4.66B to 20.26B, an increase of 334.75%. That is a compound annual growth rate of 7.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 20.26B | -6.38% |
| Dec 31, 2025 | 21.64B | -29.33% |
| Dec 31, 2024 | 30.62B | -15.91% |
| Dec 29, 2023 | 36.42B | -2.82% |
| Dec 30, 2022 | 37.47B | -10.49% |
| Dec 31, 2021 | 41.86B | 49.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aarti Pharmalabs | 60.48B |
| Innova Captab | 55.75B |
| Orchid Pharma | 50.04B |
| RPG Life Sciences | 45.78B |
| Solara Active Pharma Sciences | 24.74B |
| Beta Drugs | 22.53B |
| Sakar Healthcare | 19.70B |
| Ind-Swift Laboratories | 19.45B |